BRCA1alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy
出版年份 2017 全文链接
标题
BRCA1alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy
作者
关键词
-
出版物
GENES CHROMOSOMES & CANCER
Volume 56, Issue 5, Pages 405-420
出版商
Wiley
发表日期
2017-01-26
DOI
10.1002/gcc.22445
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted sequencing ofBRCA1andBRCA2across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
- (2016) C. Winter et al. ANNALS OF ONCOLOGY
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy
- (2016) Robert Fred Henry Walter et al. Journal of Cancer
- Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study
- (2015) Claudia Lundgren et al. ACTA ONCOLOGICA
- The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription
- (2015) Rebekka A. Schwab et al. MOLECULAR CELL
- Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy
- (2015) Ukhyun Jo et al. MOLECULES AND CELLS
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
- (2015) Rohit Prakash et al. Cold Spring Harbor Perspectives in Biology
- c-Myc Suppression of DNA Double-strand Break Repair
- (2015) Zhaozhong Li et al. NEOPLASIA
- Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy
- (2013) Mamoru Takada et al. BMC CANCER
- Mechanisms of resistance to therapies targeting BRCA-mutant cancers
- (2013) Christopher J Lord et al. NATURE MEDICINE
- Synthetic lethality between CCNE1 amplification and loss of BRCA1
- (2013) D. Etemadmoghadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression
- (2012) Amanjit Bal et al. VIRCHOWS ARCHIV
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
- (2010) M. A. Vollebergh et al. ANNALS OF ONCOLOGY
- MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks
- (2010) T. Hayakawa et al. JOURNAL OF CELL SCIENCE
- Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
- (2008) C. S. Walsh et al. CLINICAL CANCER RESEARCH
- The methylation status ofRASSF1Apromoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients
- (2008) Shohei Honda et al. INTERNATIONAL JOURNAL OF CANCER
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
- (2008) Yutaka Kondo et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started